Live Cell Imaging Supports a Key Role for Histone Deacetylase as a Molecular Target during Glioblastoma Malignancy Downgrade through Tumor Competence Modulation

Glioblastoma (GBM) is the most aggressive tumor of the central nervous system, and the identification of the mechanisms underlying the biological basis of GBM aggressiveness is essential to develop new therapies. Due to the low prognosis of GBM treatment, different clinical studies are in course to...

Full description

Bibliographic Details
Main Authors: Aline Menezes, Gustavo Henrique dos Reis, Maria Cecília Oliveira-Nunes, Fernanda Mariath, Mariana Cabanel, Bruno Pontes, Newton Gonçalves Castro, José Marques de Brito, Katia Carneiro
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Oncology
Online Access:http://dx.doi.org/10.1155/2019/9043675